Palisade Bio (PALI) Cash & Equivalents Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -68.22% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 988.88% |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.00% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 15.64% |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 4.77% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 17.50% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 3.35% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -4.13% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 67.78% |
| 10 | Palisade Bio | 439.25 Mn | 309.68 Mn | - | 1,692.12% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,692.12% |
| Dec 31, 2025 | 1,256.13% |
| Sep 30, 2025 | -34.99% |
| Jun 30, 2025 | -52.29% |
| Mar 31, 2025 | -35.88% |
| Dec 31, 2024 | -21.47% |
| Sep 30, 2024 | -47.49% |
| Jun 30, 2024 | -30.79% |
| Mar 31, 2024 | -15.20% |
| Dec 31, 2023 | 0.40% |
| Sep 30, 2023 | 9.49% |
| Jun 30, 2023 | 229.38% |
| Mar 31, 2023 | 100.14% |
| Dec 31, 2022 | 17.99% |
| Sep 30, 2022 | -0.84% |
| Jun 30, 2022 | -60.64% |
| Mar 31, 2022 | 980.33% |
| Dec 31, 2021 | 1,371.95% |
| Sep 30, 2021 | 1,778.03% |
| Jun 30, 2021 | 732.98% |
| Mar 31, 2021 | -93.87% |
| Dec 31, 2020 | -86.06% |
| Sep 30, 2020 | -89.71% |
| Jun 30, 2020 | -33.42% |
| Mar 31, 2020 | 150.43% |
| Dec 31, 2019 | -11.62% |
| Sep 30, 2019 | 27.24% |
| Jun 30, 2019 | -67.83% |
| Mar 31, 2019 | -58.81% |
| Dec 31, 2018 | -13.30% |
| Sep 30, 2018 | -36.70% |
| Jun 30, 2018 | 10.09% |
| Mar 31, 2018 | -16.75% |
| Dec 31, 2017 | -56.07% |
| Sep 30, 2017 | 59.68% |
| Jun 30, 2017 | -42.11% |
| Mar 31, 2017 | 53.27% |
| Dec 31, 2016 | 222.16% |
| Sep 30, 2016 | -56.77% |
| Jun 30, 2016 | 28.67% |
| Mar 31, 2016 | -43.94% |
| Dec 31, 2015 | -62.32% |
| Sep 30, 2015 | 9.92% |
| Jun 30, 2015 | -43.22% |
| Mar 31, 2015 | -25.89% |
| Dec 31, 2014 | -25.69% |
| Sep 30, 2014 | -27.17% |
| Jun 30, 2014 | 36.42% |
| Mar 31, 2014 | 44.90% |
| Dec 31, 2013 | 126.31% |
| Sep 30, 2013 | 66.12% |
| Jun 30, 2013 | 339.69% |
| Mar 31, 2013 | 146.09% |
| Dec 31, 2012 | 216.49% |
| Sep 30, 2012 | 135.33% |
| Jun 30, 2012 | -58.65% |
| Mar 31, 2012 | -39.81% |
| Dec 31, 2011 | -74.60% |
| Sep 30, 2011 | -63.80% |
| Jun 30, 2011 | -56.21% |